Journalists' views on media coverage of medical tests and overdiagnosis: a qualitative study.
medical journalism
preventive medicine
public health
qualitative research
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
01 06 2021
01 06 2021
Historique:
entrez:
3
6
2021
pubmed:
4
6
2021
medline:
22
6
2021
Statut:
epublish
Résumé
Promotional media coverage of early detection tests is an important driver of overdiagnosis. Following research evidence that global media coverage presents the benefits of testing healthy people far more frequently than harms, and gives little coverage to overdiagnosis, we sought to examine journalists' views on media reporting of tests, overdiagnosis, and strategies to improve critical reporting on tests. Qualitative study using semistructured telephone interviews. Interviews were conducted between February and March 2020 and were audiorecorded and transcribed verbatim. Framework thematic analysis was used to analyse the data. Twenty-two journalists (mainly specialising in health reporting, average 14.5 years' experience) based in Australia. This sample of journalists acknowledged the potential harms of medical tests but felt that knowledge of harms was low among journalists and the public at large. Most were aware of the term overdiagnosis, but commonly felt that it is challenging to both understand and communicate in light of strong beliefs in the benefits of early detection. Journalists felt that newsworthiness in the form of major public health impact was the key ingredient for stories about medical tests. The journalists acknowledged that factors, like the press release and 'click bait culture' in particular, can influence the framing of coverage about tests. Lack of knowledge and training, as well as time pressures, were perceived to be the main barriers to critical reporting on tests. Journalists felt that training and better access to information about potential harms would enable more critical reporting. Effectively communicating overdiagnosis is a challenge in light of common beliefs about the benefits of testing and the culture of current journalism practices. Providing journalists with training, support and better access to information about potential harms of tests could aid critical reporting of tests.
Identifiants
pubmed: 34078634
pii: bmjopen-2020-043991
doi: 10.1136/bmjopen-2020-043991
pmc: PMC8173287
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e043991Informations de copyright
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: RM and AB are members of the Scientific Committee of the Preventing Overdiagnosis international conferences. CM, KM, AB and RM are lead investigators on Wiser Healthcare, a research collaboration to reduce overdiagnosis and overtreatment.
Références
Eur Heart J Cardiovasc Pharmacother. 2020 Nov 1;6(6):405-407
pubmed: 32065653
JAMA Intern Med. 2017 Mar 1;177(3):407-419
pubmed: 28097303
CMAJ. 2003 Apr 29;168(9):1133-7
pubmed: 12719316
Lancet. 2017 Jul 8;390(10090):156-168
pubmed: 28077234
BMJ. 2017 Aug 16;358:j3879
pubmed: 28814436
BMJ. 2012 Jan 27;344:d8164
pubmed: 22286507
Soc Sci Med. 1994 Feb;38(4):637-43
pubmed: 8184327
BMC Public Health. 2018 Oct 30;18(1):1212
pubmed: 30376841
BMJ. 2019 Sep 13;366:l5270
pubmed: 31519649
BMC Public Health. 2010 Sep 08;10:535
pubmed: 20822552
N Engl J Med. 2016 Aug 18;375(7):614-7
pubmed: 27532827
N Engl J Med. 2000 Jun 1;342(22):1645-50
pubmed: 10833211
J Med Ethics. 2016 Nov;42(11):705-714
pubmed: 27402883
BMJ. 2015 Mar 04;350:h869
pubmed: 25740625
JAMA Intern Med. 2015 Feb;175(2):274-86
pubmed: 25531451
BMJ Open. 2016 Apr 06;6(4):e010723
pubmed: 27053274
BMJ. 2018 Aug 17;362:k3494
pubmed: 30120097
JAMA Intern Med. 2019 Nov 1;179(11):1568-1574
pubmed: 31498374
JAMA. 2019 Feb 26;321(8):739-740
pubmed: 30735228
JAMA. 2019 Jan 1;321(1):80-96
pubmed: 30620375
J Eval Clin Pract. 2018 Oct;24(5):978-982
pubmed: 29790242
BMJ. 2017 May 8;357:j2102
pubmed: 28483750
Cochrane Database Syst Rev. 2002;(1):CD000389
pubmed: 11869574
Vaccine. 2020 Jan 10;38(2):271-277
pubmed: 31699506
Lancet. 2010 Oct 9;376(9748):1261-71
pubmed: 20933263
JAMA Intern Med. 2021 Jun 1;181(6):865-867
pubmed: 33818597
N Engl J Med. 2014 Nov 6;371(19):1765-7
pubmed: 25372084
PLoS One. 2015 May 20;10(5):e0125165
pubmed: 25992887
JAMA Intern Med. 2015 Nov;175(11):1856-8
pubmed: 26390245
Med J Aust. 2020 Mar;212(4):163-168
pubmed: 31858624
PLoS One. 2019 Sep 12;14(9):e0220897
pubmed: 31513581
Health Commun. 2018 Feb;33(2):202-211
pubmed: 27982702
BMJ. 2014 Dec 09;349:g7015
pubmed: 25498121
PLoS Med. 2008 May 27;5(5):e95
pubmed: 18507496
BMJ. 2012 May 28;344:e3502
pubmed: 22645185
Int J Qual Health Care. 2007 Dec;19(6):349-57
pubmed: 17872937
Health Expect. 2003 Dec;6(4):323-31
pubmed: 15040794
JAMA. 2004 Jan 7;291(1):71-8
pubmed: 14709578
N Engl J Med. 2016 Oct 13;375(15):1438-1447
pubmed: 27732805
Eur J Epidemiol. 2019 Jul;34(7):613-619
pubmed: 30796581
J Natl Cancer Inst. 2009 Dec 2;101(23):1596-9
pubmed: 19933445
Med J Aust. 2005 Sep 5;183(5):247-50
pubmed: 16138798
Disabil Rehabil. 2020 Apr 3;:1-29
pubmed: 32242464
JAMA Oncol. 2016 Jan;2(1):139-41
pubmed: 26512913
BMJ. 2020 Jun 24;369:m2456
pubmed: 32580930
Ann Intern Med. 2004 Feb 3;140(3):226-8
pubmed: 14757622
JAMA Intern Med. 2019 Feb 1;179(2):272-273
pubmed: 30592488
Ann Intern Med. 2019 Feb 19;170(4):259-261
pubmed: 30716768